Clinical Trial Update: Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravenous dexmedetomidine for prevention of spinal anesthesia-induced shivering in cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Delivery-related Complications Cannot Be Inferred As Disease Focusing On Postoperative Shivering in the Context of Cesarean Delivery
• Postoperative Shivering

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Rehman Medical Institute - RMI | Conditions: Postoperative Shivering, Cesarean Delivery | Phase 4 | Status: UNKNOWN